Smart drug delivery systems for precise cancer therapy

Xiaoyou Wang; Chong Li; Yiguang Wang; Huabing Chen; Xinxin Zhang; Cong Luo; Wenhu Zhou; Lili Li; Lesheng Teng; Haijun Yu; Jiancheng Wang

Acta Pharmaceutica Sinica B (Nov 2022)

Smart drug delivery systems for precise cancer therapy

Xiaoyou Wang,
Chong Li,
Yiguang Wang,
Huabing Chen,
Xinxin Zhang,
Cong Luo,
Wenhu Zhou,
Lili Li,
Lesheng Teng,
Haijun Yu,
Jiancheng Wang

Affiliations

Xiaoyou Wang: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China
Chong Li: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China; Corresponding authors. Tel./fax: +86 10 82805932 (Jiancheng Wang), +86 023 68251225 (Chong Li).
Yiguang Wang: Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
Huabing Chen: School of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China
Xinxin Zhang: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Cong Luo: Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
Wenhu Zhou: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China
Lili Li: CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing 100190, China
Lesheng Teng: School of Life Sciences, Jilin University, Changchun 130012, China
Haijun Yu: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Jiancheng Wang: Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Corresponding authors. Tel./fax: +86 10 82805932 (Jiancheng Wang), +86 023 68251225 (Chong Li).

Journal volume & issue: Vol. 12, no. 11
pp. 4098 – 4121

Abstract

Read online

Nano-drug delivery strategies have been highlighted in cancer treatment, and much effort has been made in the optimization of bioavailability, biocompatibility, pharmacokinetics profiles, and in vivo distributions of anticancer nano-drug delivery systems. However, problems still exist in the delicate balance between improved anticancer efficacy and reduced toxicity to normal tissues, and opportunities arise along with the development of smart stimuli-responsive delivery strategies. By on-demand responsiveness towards exogenous or endogenous stimulus, these smart delivery systems hold promise for advanced tumor-specificity as well as controllable release behavior in a spatial-temporal manner. Meanwhile, the blossom of nanotechnology, material sciences, and biomedical sciences has shed light on the diverse modern drug delivery systems with smart characteristics, versatile functions, and modification possibilities. This review summarizes the current progress in various strategies for smart drug delivery systems against malignancies and introduces the representative endogenous and exogenous stimuli-responsive smart delivery systems. It may provide references for researchers in the fields of drug delivery, biomaterials, and nanotechnology.

Published in Acta Pharmaceutica Sinica B

ISSN: 2211-3835 (Print); 2211-3843 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: http://www.journals.elsevier.com/acta-pharmaceutica-sinica-b

About the journal

Abstract

Keywords